NABRIVA THERAPEUTICS PLC (NBRV) Earnings History & Surprises

NASDAQ:NBRV • IE000OZRGNV6

Current stock price

1.42 USD
0 (0%)
At close:
1.3986 USD
-0.02 (-1.51%)
After Hours:

NBRV Earnings overview

Past quarterly earnings results for NABRIVA THERAPEUTICS PLC (NBRV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A
Period
Q2 / 2023
EPS Estimate
-$2.35
Revenue Estimate
17.748M

Last Reported

Most Recent
Release Date
Aug 10, 2023
Period
Q1 / 2023
EPS Reported
EPS Surprise
%
Revenue Surprise
-42.32%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2023 -3.44 - 31.25% 7.59M 13.158M -42.32% -5.36%
Q4 2022 -3.99 - 33.53% 10.571M 11.258M -6.10% 14.15%
Q3 2022 -4.21 -4.11 -2.55% -701.90% 9.153M 10.889M -15.94% 3.28%
Q2 2022 -4.50 -5.10 11.76% 37.93% 9.191M 8.701M 5.63% 11.50%
Q1 2022 -5.00 -4.85 -3.20% 62.26% 8.02M 9.767M -17.89% 217.00%
Q4 2021 -6.00 -4.85 -23.84% 78.38% 9.261M 10.301M -10.10% 276.46%
Q3 2021 -0.53 -6.25 91.60% 97.67% 8.862M 9.69M -8.54% 586.98%
Q2 2021 -7.25 -8.84 17.99% 79.29% 8.243M 6.105M 35.02% 1,582.24%
Q1 2021 -13.25 -17.09 22.45% 78.80% 2.53M 2.295M 10.24% 220.25%
Q4 2020 -27.75 -24.23 -14.55% - 2.46M 615.57K 299.63% -
Q3 2020 -22.50 -24.86 9.50% - 1.29M 459K 181.05% -
Q2 2020 -35.00 -40.80 14.22% - 490K 408K 20.10% -
Q1 2020 -62.50 -67.32 7.16% - 790K 466.905K 69.20% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

NBRV EPS Q2Q GrowthNBRV EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 -200 -400 -600

Revenue Historical Q2Q growth and Acceleration

NBRV Revenue Q2Q GrowthNBRV Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 500 1K 1.5K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
-14.68%
Max Revenue beat (4)
5.63%
Min Revenue beat (4)
-42.32%

Analysis

NBRV has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, NBRV reported -14.7% below the revenue estimates on average.
NBRV Overview NBRV Technical Analysis Report NBRV Fundamental Analysis Report NBRV Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

NABRIVA THERAPEUTICS PLC / NBRV Earnings FAQ

What is the most recent earnings date for NBRV stock?

NABRIVA THERAPEUTICS PLC (NBRV) last reported earnings on 8/10/2023.

Can you provide information on whether NABRIVA THERAPEUTICS PLC beat earnings estimates in the last quarter?

NABRIVA THERAPEUTICS PLC (NBRV) missed EPS estimates and missed revenue estimates in the most recent quarter.